RISHI CHADHA

BRIDGEPORT, CT NPI 1114487485

General Payments — all program years on this page

$3,450.66

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 43
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,718.55 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,718.5521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $237.343
2023 $1,494.7719
2024 $1,718.5521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078370129 Janssen Biotech, Inc. $149.89 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078370685 Janssen Biotech, Inc. $17.74 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078370743 Janssen Biotech, Inc. $24.12 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092251336 Boston Scientific Corporation $67.95 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092251338 Boston Scientific Corporation $74.26 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092251340 Boston Scientific Corporation $96.09 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092251342 Boston Scientific Corporation $125.61 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092251344 Boston Scientific Corporation $149.94 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103433992 ABBVIE INC. $149.93 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103433994 ABBVIE INC. $125.00 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103433996 ABBVIE INC. $17.61 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103433998 ABBVIE INC. $125.00 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116860298 Medtronic, Inc. $78.53 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133840604 Gilead Sciences, Inc. $101.29 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137505838 Takeda Pharmaceuticals U.S.A., Inc. $17.69 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137505842 Takeda Pharmaceuticals U.S.A., Inc. $49.82 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137505845 Takeda Pharmaceuticals U.S.A., Inc. $71.73 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142397035 CONMED Corporation $77.57 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145054995 Mallinckrodt Hospital Products Inc. $27.77 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146965678 AIMMUNE THERAPEUTICS, INC. $50.76 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151047220 Phathom Pharmaceuticals, Inc. $120.25 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.